Share Price and Basic Stock Data
Last Updated: January 28, 2026, 3:14 pm
| PEG Ratio | -8.94 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ambani Organics Ltd operates in the organic chemicals sector, with a current market capitalization of ₹79.6 Cr. The company reported a share price of ₹104, with a price-to-earnings (P/E) ratio of 126, which reflects a high valuation relative to its earnings. Revenue from operations demonstrated a consistent growth trajectory, increasing from ₹52 Cr in FY 2017 to ₹223 Cr in the trailing twelve months (TTM). The quarterly sales figures show fluctuations, with the most recent quarter, Mar 2024, recording sales of ₹74 Cr, up from ₹66 Cr in Mar 2023. However, the Sep 2023 sales declined to ₹62 Cr, indicating potential volatility in demand. Over the years, the company has achieved a maximum annual sales figure of ₹136 Cr in FY 2024, highlighting a robust growth trend despite some quarterly declines. The overall revenue growth, alongside a diverse product offering, positions Ambani Organics favorably within the organic chemicals industry.
Profitability and Efficiency Metrics
Profitability metrics for Ambani Organics Ltd reveal a mixed performance. The operating profit margin (OPM) stood at 7% for FY 2025, reflecting a decline from 6% in the previous year. The company recorded a net profit of ₹1 Cr in FY 2023, which remained static in FY 2024 at ₹3 Cr, before dropping to a net loss of ₹1 Cr in FY 2025. This inconsistency is reflected in the earnings per share (EPS), which fluctuated from ₹1.73 in Mar 2023 to -₹2.11 in Mar 2025. The interest coverage ratio (ICR) of 1.39x indicates that the company can cover its interest expenses, although it remains on the lower side compared to industry norms. The cash conversion cycle reported at -29 days in FY 2025 suggests efficient management of working capital, with a reduced need for financing. However, the low return on equity (ROE) of 0.04% signals challenges in generating shareholder returns, which could deter potential investors.
Balance Sheet Strength and Financial Ratios
Ambani Organics Ltd’s balance sheet reflects a growing asset base, with total assets reported at ₹208 Cr in FY 2025, up from ₹176 Cr in FY 2024. Borrowings stood at ₹61 Cr, indicating a significant reliance on debt financing, which is evident from the total debt-to-equity ratio of 1.05x. The reserves have increased to ₹44 Cr, showcasing a strengthening equity position. However, the company’s current ratio of 1.01x suggests a tight liquidity position, which could pose risks if unexpected expenses arise. The price-to-book value ratio at 1.73x indicates that the stock is trading at a premium compared to its book value, which may reflect market expectations of future growth. Additionally, the inventory turnover ratio of 5.51x points to effective inventory management, although the operating profit has been under pressure due to rising expenses. Overall, while the balance sheet shows growth potential, the high leverage and liquidity challenges warrant caution.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambani Organics Ltd reveals significant promoter confidence, with promoters holding 61.25% of the shares as of Mar 2025. This stability in promoter holdings has remained consistent, suggesting a long-term commitment to the company’s growth. The public shareholding stands at 38.75%, reflecting a healthy distribution of ownership among retail investors. The number of shareholders has fluctuated, peaking at 293 in Sep 2024 before declining to 280 in Sep 2025. This slight decrease may indicate investor caution amidst recent financial performance. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) can be seen as a potential risk, as it may limit the stock’s visibility and liquidity. However, sustained promoter ownership can signal confidence in the company’s strategic direction, which may encourage retail investors to maintain or increase their stakes.
Outlook, Risks, and Final Insight
Looking ahead, Ambani Organics Ltd faces both opportunities and challenges. The company’s ability to navigate revenue volatility and improve profitability will be crucial. Risks include high leverage and tight liquidity, which could strain operations during downturns. Additionally, the fluctuating net profit and low ROE raise concerns about operational efficiency and shareholder returns. Strengths such as a solid revenue growth trajectory and efficient inventory management provide a foundation for improvement. The management’s response to market dynamics and cost control will be pivotal in enhancing profitability. If Ambani Organics can leverage its strong promoter backing to attract institutional investors and stabilize earnings, it may unlock greater shareholder value. However, failure to address financial stability could impede growth and investor confidence. Overall, while the company has strengths to build upon, addressing existing weaknesses will be critical to its future success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 59.4 Cr. | 166 | 437/135 | 138 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 6,499 Cr. | 8,198 | 14,250/8,025 | 47.0 | 1,177 | 0.09 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 26.2 Cr. | 87.4 | 329/84.1 | 13.0 | 26.9 | 1.14 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 205 Cr. | 256 | 435/163 | 11.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,368.08 Cr | 1,392.78 | 55.68 | 334.84 | 0.45% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38 | 36 | 26 | 61 | 67 | 59 | 67 | 66 | 62 | 74 | 82 | 112 | 111 |
| Expenses | 35 | 33 | 24 | 57 | 64 | 55 | 64 | 61 | 58 | 74 | 77 | 106 | 103 |
| Operating Profit | 3 | 3 | 2 | 4 | 3 | 4 | 4 | 5 | 5 | 0 | 4 | 6 | 8 |
| OPM % | 7% | 8% | 9% | 7% | 5% | 7% | 5% | 7% | 8% | 0% | 5% | 6% | 7% |
| Other Income | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 5 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 5 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 1 | 1 | 0 | 2 | 1 | 2 | 1 | 2 | 0 | -0 | -1 | 2 | 1 |
| Tax % | 43% | 21% | 24% | 38% | 32% | 26% | 26% | 41% | 63% | -5,960% | 33% | 47% | 87% |
| Net Profit | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 3 | -2 | 1 | 0 |
| EPS in Rs | 1.14 | 1.59 | 0.71 | 2.64 | 1.46 | 1.97 | 1.35 | 1.73 | 0.16 | 4.15 | -2.52 | 1.21 | 0.25 |
Last Updated: January 13, 2026, 4:16 am
Below is a detailed analysis of the quarterly data for Ambani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 111.00 Cr., marking a decrease of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 103.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 106.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 7.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2025) to 7.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 87.00%. The value appears to be increasing, which may not be favorable. It has increased from 47.00% (Mar 2025) to 87.00%, marking an increase of 40.00%.
- For Net Profit, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.25. The value appears to be declining and may need further review. It has decreased from 1.21 (Mar 2025) to 0.25, marking a decrease of 0.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:40 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 65 | 79 | 73 | 87 | 125 | 132 | 136 | 193 | 223 |
| Expenses | 49 | 60 | 74 | 68 | 81 | 118 | 124 | 131 | 183 | 208 |
| Operating Profit | 3 | 5 | 6 | 5 | 6 | 6 | 8 | 5 | 9 | 14 |
| OPM % | 6% | 7% | 7% | 7% | 7% | 5% | 6% | 3% | 5% | 6% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 5 | 2 | 0 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 8 | 8 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 |
| Profit before tax | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 0 | 0 | 3 |
| Tax % | 32% | 17% | 28% | 39% | 35% | 28% | 35% | -1,116% | 300% | |
| Net Profit | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | -1 | 1 |
| EPS in Rs | 2.10 | 4.64 | 3.41 | 2.72 | 3.35 | 3.12 | 3.08 | 4.31 | -1.11 | 1.46 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 0.00% | -50.00% | 100.00% | 0.00% | 0.00% | 50.00% | -133.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.00% | -50.00% | 150.00% | -100.00% | 0.00% | 50.00% | -183.33% |
Ambani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 16% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 21% |
| 1 Year: | 43% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 4, 2025, 11:00 pm
Balance Sheet
Last Updated: January 7, 2026, 3:21 pm
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 7 | 8 | 13 |
| Reserves | 0 | 2 | 10 | 12 | 13 | 24 | 26 | 39 | 44 | 44 |
| Borrowings | 13 | 16 | 15 | 20 | 34 | 53 | 52 | 61 | 60 | 61 |
| Other Liabilities | 22 | 26 | 31 | 26 | 25 | 29 | 54 | 68 | 97 | 87 |
| Total Liabilities | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 | 205 |
| Fixed Assets | 12 | 13 | 13 | 15 | 21 | 22 | 21 | 59 | 77 | 84 |
| CWIP | -0 | -0 | -0 | 2 | -0 | 9 | 47 | 8 | 7 | -0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 26 | 35 | 48 | 46 | 56 | 80 | 69 | 109 | 124 | 121 |
| Total Assets | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 | 205 |
Below is a detailed analysis of the balance sheet data for Ambani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
- For Borrowings, as of Sep 2025, the value is 61.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 60.00 Cr. (Mar 2025) to 61.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 97.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 205.00 Cr.. The value appears to be improving (decreasing). It has decreased from 208.00 Cr. (Mar 2025) to 205.00 Cr., marking a decrease of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Mar 2025) to 121.00 Cr., marking a decrease of 3.00 Cr..
- For Total Assets, as of Sep 2025, the value is 205.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2025) to 205.00 Cr., marking a decrease of 3.00 Cr..
However, the Borrowings (61.00 Cr.) are higher than the Reserves (44.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.00 | -11.00 | -9.00 | -15.00 | -28.00 | -47.00 | -44.00 | -56.00 | -51.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 112 | 103 | 104 | 117 | 127 | 94 | 78 | 72 | 80 |
| Inventory Days | 53 | 70 | 95 | 102 | 92 | 75 | 77 | 100 | 103 |
| Days Payable | 129 | 131 | 134 | 100 | 81 | 63 | 142 | 194 | 213 |
| Cash Conversion Cycle | 35 | 42 | 65 | 118 | 138 | 105 | 13 | -22 | -29 |
| Working Capital Days | -8 | 3 | 31 | 42 | 36 | 17 | -14 | 20 | -29 |
| ROCE % | 22% | 20% | 15% | 12% | 9% | 9% | 2% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.11 | -12.80 | 1.07 | 3.06 | 3.35 |
| Diluted EPS (Rs.) | -2.11 | -12.80 | 1.07 | 3.06 | 3.35 |
| Cash EPS (Rs.) | 2.90 | 8.32 | 5.34 | 5.32 | 5.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 66.82 | 65.64 | 49.70 | 47.69 | 36.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 66.82 | 65.64 | 49.70 | 47.69 | 36.49 |
| Revenue From Operations / Share (Rs.) | 253.21 | 192.96 | 206.42 | 195.94 | 170.65 |
| PBDIT / Share (Rs.) | 14.10 | 7.23 | 13.51 | 11.51 | 12.99 |
| PBIT / Share (Rs.) | 10.08 | 3.23 | 11.24 | 9.31 | 10.96 |
| PBT / Share (Rs.) | 0.56 | -10.05 | 4.69 | 4.36 | 5.14 |
| Net Profit / Share (Rs.) | -1.12 | 4.31 | 3.07 | 3.13 | 3.35 |
| NP After MI And SOA / Share (Rs.) | -1.12 | 4.31 | 3.07 | 3.13 | 3.35 |
| PBDIT Margin (%) | 5.56 | 3.74 | 6.54 | 5.87 | 7.61 |
| PBIT Margin (%) | 3.98 | 1.67 | 5.44 | 4.75 | 6.42 |
| PBT Margin (%) | 0.22 | -5.20 | 2.27 | 2.22 | 3.01 |
| Net Profit Margin (%) | -0.44 | 2.23 | 1.48 | 1.59 | 1.96 |
| NP After MI And SOA Margin (%) | -0.44 | 2.23 | 1.48 | 1.59 | 1.96 |
| Return on Networth / Equity (%) | -1.67 | 6.56 | 6.18 | 6.55 | 9.18 |
| Return on Capital Employeed (%) | 8.95 | 2.74 | 10.23 | 10.50 | 16.54 |
| Return On Assets (%) | -0.41 | 1.73 | 1.43 | 1.79 | 2.18 |
| Long Term Debt / Equity (X) | 0.42 | 0.50 | 0.73 | 0.37 | 0.32 |
| Total Debt / Equity (X) | 1.05 | 1.19 | 2.09 | 1.54 | 1.70 |
| Asset Turnover Ratio (%) | 1.01 | 0.87 | 1.06 | 1.33 | 1.23 |
| Current Ratio (X) | 1.01 | 1.15 | 1.01 | 1.30 | 1.27 |
| Quick Ratio (X) | 0.67 | 0.83 | 0.66 | 0.91 | 0.86 |
| Inventory Turnover Ratio (X) | 5.51 | 4.29 | 5.17 | 5.06 | 4.34 |
| Interest Coverage Ratio (X) | 1.39 | 0.75 | 2.08 | 2.32 | 2.19 |
| Interest Coverage Ratio (Post Tax) (X) | 0.82 | 0.75 | 1.48 | 1.63 | 1.55 |
| Enterprise Value (Cr.) | 131.77 | 126.46 | 118.61 | 112.99 | 51.85 |
| EV / Net Operating Revenue (X) | 0.67 | 0.92 | 0.89 | 0.89 | 0.59 |
| EV / EBITDA (X) | 12.20 | 24.77 | 13.65 | 15.26 | 7.86 |
| MarketCap / Net Operating Revenue (X) | 0.45 | 0.53 | 0.39 | 0.56 | 0.26 |
| Price / BV (X) | 1.73 | 1.57 | 1.63 | 2.31 | 1.26 |
| Price / Net Operating Revenue (X) | 0.45 | 0.53 | 0.39 | 0.56 | 0.26 |
| EarningsYield | -0.01 | 0.04 | 0.03 | 0.02 | 0.07 |
After reviewing the key financial ratios for Ambani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 5. It has increased from -12.80 (Mar 24) to -2.11, marking an increase of 10.69.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 5. It has increased from -12.80 (Mar 24) to -2.11, marking an increase of 10.69.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 3. It has decreased from 8.32 (Mar 24) to 2.90, marking a decrease of 5.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.82. It has increased from 65.64 (Mar 24) to 66.82, marking an increase of 1.18.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.82. It has increased from 65.64 (Mar 24) to 66.82, marking an increase of 1.18.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 253.21. It has increased from 192.96 (Mar 24) to 253.21, marking an increase of 60.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 14.10. This value is within the healthy range. It has increased from 7.23 (Mar 24) to 14.10, marking an increase of 6.87.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.08. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 10.08, marking an increase of 6.85.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.56. This value is within the healthy range. It has increased from -10.05 (Mar 24) to 0.56, marking an increase of 10.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 2. It has decreased from 4.31 (Mar 24) to -1.12, marking a decrease of 5.43.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 2. It has decreased from 4.31 (Mar 24) to -1.12, marking a decrease of 5.43.
- For PBDIT Margin (%), as of Mar 25, the value is 5.56. This value is below the healthy minimum of 10. It has increased from 3.74 (Mar 24) to 5.56, marking an increase of 1.82.
- For PBIT Margin (%), as of Mar 25, the value is 3.98. This value is below the healthy minimum of 10. It has increased from 1.67 (Mar 24) to 3.98, marking an increase of 2.31.
- For PBT Margin (%), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 10. It has increased from -5.20 (Mar 24) to 0.22, marking an increase of 5.42.
- For Net Profit Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 5. It has decreased from 2.23 (Mar 24) to -0.44, marking a decrease of 2.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 8. It has decreased from 2.23 (Mar 24) to -0.44, marking a decrease of 2.67.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.67. This value is below the healthy minimum of 15. It has decreased from 6.56 (Mar 24) to -1.67, marking a decrease of 8.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.95. This value is below the healthy minimum of 10. It has increased from 2.74 (Mar 24) to 8.95, marking an increase of 6.21.
- For Return On Assets (%), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has decreased from 1.73 (Mar 24) to -0.41, marking a decrease of 2.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.50 (Mar 24) to 0.42, marking a decrease of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.05. This value exceeds the healthy maximum of 1. It has decreased from 1.19 (Mar 24) to 1.05, marking a decrease of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has increased from 0.87 (Mar 24) to 1.01, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.01, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.83 (Mar 24) to 0.67, marking a decrease of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.51. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 5.51, marking an increase of 1.22.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 1.39, marking an increase of 0.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.82, marking an increase of 0.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 131.77. It has increased from 126.46 (Mar 24) to 131.77, marking an increase of 5.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.67, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 24.77 (Mar 24) to 12.20, marking a decrease of 12.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 1.73, marking an increase of 0.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to -0.01, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambani Organics Ltd:
- Net Profit Margin: -0.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.95% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.67% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 126 (Industry average Stock P/E: 55.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.44%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | N-44, MIDC Tarapur, Boisar, Thane Maharashtra 401506 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Apooni R Shah | Chairman & Wholetime Director |
| Mr. Rakesh H Shah | Managing Director |
| Mr. Bhavin Jitendra Patel | Non Exe.Non Ind.Director |
| Mr. Neerajkumar A Pandey | Ind. Non-Executive Director |
| Mr. Sanjay N Mehta | Independent Director |
| Dr. Prakash A Mahanwar | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Ambani Organics Ltd?
Ambani Organics Ltd's intrinsic value (as of 29 January 2026) is ₹2.63 which is 97.47% lower the current market price of ₹104.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹79.6 Cr. market cap, FY2025-2026 high/low of ₹144/94.9, reserves of ₹44 Cr, and liabilities of ₹205 Cr.
What is the Market Cap of Ambani Organics Ltd?
The Market Cap of Ambani Organics Ltd is 79.6 Cr..
What is the current Stock Price of Ambani Organics Ltd as on 29 January 2026?
The current stock price of Ambani Organics Ltd as on 29 January 2026 is ₹104.
What is the High / Low of Ambani Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambani Organics Ltd stocks is ₹144/94.9.
What is the Stock P/E of Ambani Organics Ltd?
The Stock P/E of Ambani Organics Ltd is 126.
What is the Book Value of Ambani Organics Ltd?
The Book Value of Ambani Organics Ltd is 74.5.
What is the Dividend Yield of Ambani Organics Ltd?
The Dividend Yield of Ambani Organics Ltd is 0.00 %.
What is the ROCE of Ambani Organics Ltd?
The ROCE of Ambani Organics Ltd is 7.12 %.
What is the ROE of Ambani Organics Ltd?
The ROE of Ambani Organics Ltd is 0.04 %.
What is the Face Value of Ambani Organics Ltd?
The Face Value of Ambani Organics Ltd is 10.0.